.webp)
Principal Consultant
Deepa Pandey, one of our esteemed authors, plays a crucial role in shaping the high-quality content that defines our research reports. Deepa holds a Master's in Pharmacy with a specialization in Pharmaceutical Quality Assurance, equipping her with an in-depth understanding of the healthcare industry's regulatory, quality, and operational nuances. With 5+ years of experience in market research, Deepa has made her mark by working on over 70 reports across multiple domains, with a primary focus on the healthcare sector.
Her passion for secondary research and her analytical mindset has enabled her to dive deep into complex market dynamics, exploring everything from pharmaceutical innovations to healthcare policies. Deepa’s commitment to addressing unanswered questions and her eagerness to tackle emerging challenges have fueled her success in this fast-paced industry.
With Deepa’s extensive knowledge and dedication to research excellence, her reports continue to set the standard for quality and reliability in the healthcare market research domain.
Her expertise lies in identifying emerging trends, understanding market drivers, and uncovering opportunities within healthcare segments. Whether it's exploring pharmaceutical advancements, healthcare infrastructure, or regulatory shifts, Deepa’s work provides valuable, actionable insights that help our clients make informed decisions and stay ahead of the competition.
No Media Citations Found.
With more than five years of healthcare and medical device market analysis experience, Payal Rabde believes the medical device contract sales organizations market is now in a new phase. Contract sales organisations are becoming an increasingly important part of traditional sales organisations. As manufacturers adopt more flexible commercial models, pressure to manage selling costs grows, and there is an increasing need for specialized sales skills.
Payal Rabde has more than 5 years of experience in medical device and chronic care healthcare analysis. She believes that the ostomy care market is transitioning to a more patient-centric phase. As colorectal cancer is becoming more prevalent in society, patients are becoming more aware of effective ostomy care. With innovations in pouching technology and skin protection products, patients are having more options that will allow them to enjoy more comfortable and reliable long-term care. The global ostomy care market was valued at USD 3.84 billion in 2025 and is growing at a CAGR of 4.46% over the forecast period. Additionally, the number of elderly citizens and the increasing incidence of colorectal and gastrointestinal diseases are anticipated to continue to be the drivers of market growth.
Payment integrity is moving closer to the claims-adjudication process as payers seek to identify payment errors earlier in the cycle. Claims-editing engines, clinical rules, provider-level analytics, and machine learning can flag duplicate claims, coding inconsistencies, unsupported services, unusual provider activity, and potential fraud before or shortly after payment. This does not eliminate retrospective recovery; it expands payment integrity from recovering losses after payment to preventing or reducing avoidable leakage earlier. The market was valued at USD 16.05 billion in 2025 and is projected to grow at a 14.21% CAGR through 2035.
According to Payal Rabde, who has more than 5 years' experience in healthcare research analysis. AI agents are widely used for traditional transcription services. They are replacing manual data entry and making it more efficient by minimizing errors. The need for technology that makes clinical daily tasks more efficient is driving the growth in the global AI agents for clinical documentation market. The global AI agents for clinical documentation market is projected to experience robust growth over the forecast period, as the increasing burden of documentation for physicians. This enhances clinical workflow efficiency are all contributing factor. Payal Rabde believes that the shift from passive AI transcription to agentic clinical documentation is a significant market transition.
Payal Rabde has over 5 years of experience in healthcare analysis of medical devices and renal care and notes that peritoneal dialysis is taking a new direction. With a more technology-driven approach, more patients are choosing to treat at home, evolving preferences for APD vs. CAPD, and a growing demand for connected dialysis options. The global peritoneal dialysis market size was valued at USD 10.07 billion in 2025 and is estimated to grow to USD 18.12 billion by 2035, growing at a CAGR of 6.05% during the forecast period. Payal Rabde identifies the transition from continuous to automated peritoneal dialysis, increasing home dialysis uptake in the wake of reimbursement reform. Further, a growing population of chronic kidney disease (CKD) patients in Asia-Pacific is the strongest contributor to that growth.
With over 5 years of pharmaceutical manufacturing and sterile injectable research experience into the trends of CDMO capacity, Payal Rabde believes that the market is poised to experience a real decade of capital investment instead of an incremental one. The fill finished manufacturing market for the global fill is estimated at USD 20.00 billion in 2025 and is expected to grow at 9.10% CAGR during the forecast period to reach approximately USD 47.8 billion by 2035. The commercialization of cell and gene therapies, the transition to prefilled syringes and self-administered injectables, and capacity investment in multi-billion-dollar deals like those of Novo Nordisk, Samsung Biologics, and Lonza all point to that growth, interpreted in her analysis.
The global exosome drug delivery services market size accounted for USD 4.85 billion in 2025 and is predicted to increase from USD 5.70 billion in 2026 to approximately USD 24.33 billion by 2035, expanding at a CAGR of 17.50% from 2026 to 2035.
The Middle East cyclotron-produced radioisotopes market size was valued at USD XX million in 2025 and is projected to increase from USD XX million in 2026 to approximately USD XX million by 2035, expanding at a CAGR of XX% during the forecast period from 2026 to 2035. The market is witnessing steady growth, driven by the increasing adoption of positron emission tomography (PET)-based molecular imaging, expanding cancer incidence across the Middle East, rising investments in nuclear medicine infrastructure, and growing government initiatives to establish domestic radioisotope production capabilities. The expansion of cyclotron installations, increasing demand for precision diagnostics and theranostic radiopharmaceuticals, and efforts to reduce dependence on imported short-lived radioisotopes are further supporting market growth.
The market is expected to witness significant growth, driven by increasing government interest in nuclear energy diversification, rising demand for a secure and uninterrupted supply of medical radioisotopes, advancements in Small Modular Reactor (SMR) technologies, and the growing adoption of targeted radionuclide therapies. Furthermore, increasing investments in nuclear infrastructure, localization of radioisotope production, and the development of next-generation reactor technologies are anticipated to accelerate the commercialization of SMR-based radioisotope production across the Middle East.
The global AI in cancer immunotherapy drugs market size accounted for USD 2.80 billion in 2025 and is predicted to increase from USD 3.52 billion in 2026 to approximately USD 27.79 billion by 2035, expanding at a CAGR of 25.80% from 2026 to 2035.
The global cardiac marker testing market size accounted for USD 5.45 billion in 2025 and is predicted to increase from USD 6.01 billion in 2026 to approximately USD 14.59 billion by 2035, expanding at a CAGR of 10.35% from 2026 to 2035.
The global adhesion barrier market size accounted for USD 789.00 million in 2025 and is predicted to increase from USD 846.60 million in 2026 to approximately USD 1,596.15 million by 2035, expanding at a CAGR of 7.30% from 2026 to 2035.
The global precision biotics market size accounted for USD 4.90 billion in 2025 and is predicted to increase from USD 5.56 billion in 2026 to approximately USD 17.46 billion by 2035, expanding at a CAGR of 13.55% from 2026 to 2035.
The global dental crown remover market size accounted for USD 312.00 million in 2025 and is predicted to increase from USD 330.41 million in 2026 to approximately USD 553.50 million by 2035, expanding at a CAGR of 5.90% from 2026 to 2035. The market growth is attributed to increasing restorative dental procedures and continuous advancements in precision crown removal technologies.
The global GLP-1 market size accounted for USD 58.40 billion in 2025 and is predicted to increase from USD 66.46 billion in 2026 to approximately USD 212.73 billion by 2035, expanding at a CAGR of 13.80% from 2026 to 2035. The market is driven by the expanding clinical indication of these therapies, which are now evolving from handling Type 2 diabetes to long-term chronic weight management and even cardiovascular risk reduction.
The global 3T MRI system market size accounted for USD 3.42 billion in 2025 and is predicted to increase from USD 3.65 billion in 2026 to approximately USD 6.63 billion by 2035, expanding at a CAGR of 6.85% from 2026 to 2035. The market is driven by the increasing prevalence of neurological disorders, like Alzheimer's and Parkinson's, and complex cancers, which need the superior spatial resolution and tissue contrast offered by 3T systems for early, highly accurate diagnosis.
The global electric breast pumps market size accounted for USD 1.08 billion in 2025 and is predicted to increase from USD 1.16 billion in 2026 to approximately USD 2.21 billion by 2035, expanding at a CAGR of 7.40% from 2026 to 2035. The market is driven by growing participation of women in the worldwide workforce, which is accelerating the need for efficient, portable, and time-saving pumping solutions.
The global hemodialysis and peritoneal dialysis market size accounted for USD 112.40 billion in 2025 and is predicted to increase from USD 120.16 billion in 2026 to approximately USD 219.05 billion by 2035, expanding at a CAGR of 6.90% from 2026 to 2035. The market is driven by the increasing global prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). This is directly fueled by an aging demographic and even rising rates of lifestyle-related conditions such as diabetes and hypertension.
The global CNS clinical trials market size was calculated at USD 8.65 billion in 2025 and is predicted to increase from USD 9.33 billion in 2026 to approximately USD 18.49 billion by 2035, expanding at a CAGR of 7.90% from 2026 to 2035. The market is driven by the rising global prevalence of neurodegenerative diseases, like Alzheimer's, Parkinson's, and Huntington's, combined with an aging global population.
The global decentralized clinical trials in neurology market size accounted for USD 1.48 billion in 2025 and is predicted to increase from USD 1.71 billion in 2026 to approximately USD 6.38 billion by 2035, expanding at a CAGR of 15.80% from 2026 to 2035. The increasing prevalence of neurological diseases and clinical trial activities are key growth factors for the market.
The global sevoflurane market size accounted for USD 1.15 billion in 2025 and is predicted to increase from USD 1.22 billion in 2026 to approximately USD 2.02 billion by 2035, expanding at a CAGR of 5.80% from 2026 to 2035. Growing surgical volumes, increasing healthcare expenditure, expansion of ambulatory surgical centers, rising prevalence of chronic diseases requiring surgical intervention, and advancements in anesthesia delivery systems are driving market growth.
The global brain health supplements and therapeutics market size was evaluated at USD 18.60 billion in 2025 and is anticipated to increase from USD 20.42 billion in 2026 to approximately USD 47.37 billion by 2035, expanding at a CAGR of 9.80% from 2026 to 2035. The market is driven by the rapid global aging population, which brings a rising prevalence of age-related cognitive and neurodegenerative diseases such as Alzheimer's and dementia.
The global cognitive assessment and brain health market size accounted for USD 9.40 billion in 2025 and is predicted to increase from USD 10.51 billion in 2026 to approximately USD 28.69 billion by 2035, expanding at a CAGR of 11.80% from 2026 to 2035. Rising neurological disease prevalence, growing awareness, and improved diagnosis are key factors driving growth in the market.
The US pathology laboratories market size was calculated at USD 103.84 billion in 2025 and is predicted to increase from USD 112.33 billion in 2026 to approximately USD 229.75 billion by 2035, expanding at a CAGR of 7.42% from 2026 to 2035. The market is growing due to strategic partnerships between hospitals and laboratory service providers and growing demand for oncology, neurology, autoimmune disease, and women's health testing.
The US anesthesia devices market size was calculated at USD 6.93 billion in 2025 and is predicted to increase from USD 7.41 billion in 2026 to approximately USD 14.20 billion by 2035, expanding at a CAGR of 7.44% from 2026 to 2035. The market growth is attributed to increasing surgical procedure volumes, expanding ambulatory care infrastructure, and continuous advancements in anesthesia delivery and patient monitoring technologies.
The US peptide therapeutics market size accounted for USD 21.24 billion in 2025 and is predicted to increase from USD 22.63 billion in 2026 to approximately USD 34.98 billion by 2035, expanding at a CAGR of 5.12% from 2026 to 2035. The market growth is attributed to rising obesity and diabetes prevalence, expanding peptide drug innovation, increasing GLP-1 therapy adoption, and growing investments in advanced peptide manufacturing technologies.
The US pharmaceutical stability and storage services market size accounted for USD 1.66 billion in 2025 and is predicted to increase from USD 1.76 billion in 2026 to approximately USD 2.92 billion by 2035, expanding at a CAGR of 5.81% from 2026 to 2035. The market is experiencing robust growth, driven by rising biologics and specialty drug development, expanding clinical trial activities, and stringent regulatory requirements for product quality and long-term stability testing throughout the drug development and commercialization lifecycle.
The US direct-to-consumer laboratory testing market size accounted for USD 1.23 billion in 2025 and is predicted to increase from USD 1.34 billion in 2026 to approximately USD 2.92 billion by 2035, expanding at a CAGR of 9.03% from 2026 to 2035. The market growth is attributed to rising demand for preventive healthcare, personalized diagnostics, at-home testing solutions, and increasing adoption of digital laboratory platforms.
The US regulatory affairs market size accounted for USD 4.31 billion in 2025 and is predicted to increase from USD 4.64 billion in 2026 to approximately USD 9.02 billion by 2035, expanding at a CAGR of 7.66% from 2026 to 2035. The market growth is attributed to increasing regulatory complexity, expanding healthcare innovation, rising FDA submission volumes, and growing adoption of AI-enabled regulatory technologies.
The US orthodontics market size accounted for USD 7.02 billion in 2025 and is predicted to increase from USD 7.87 billion in 2026 to approximately USD 20.63 billion by 2035, expanding at a CAGR of 11.40% from 2026 to 2035. The market is driven by rising demand for clear aligners and cosmetic dental procedures, increasing awareness of oral health, technological advancements in digital orthodontics, and escalating insurance coverage.
The US controlled substance market size accounted for USD 31.09 billion in 2025 and is predicted to increase from USD 32.74 billion in 2026 to approximately USD 52.11 billion by 2035, expanding at a CAGR of 5.70% from 2026 to 2035. The market growth is attributed to increasing prescription demand for pain management, ADHD, seizure disorders, and addiction treatment, supported by expanding healthcare access and stringent controlled-substance monitoring systems.
The US glioblastoma multiforme treatment market size accounted for USD 789.54 million in 2025 and is predicted to increase from USD 850.30 million in 2026 to approximately USD 1,634.84 million by 2035, expanding at a CAGR of 7.55% from 2026 to 2035. The market growth is attributed to the rising incidence of glioblastoma, expanding clinical research activity, and continuous advancements in precision oncology and targeted treatment technologies.
The global tylosin market size accounted for USD 920 million in 2025 and is predicted to increase from USD 969 million in 2026 to approximately USD 1,532 million by 2035, expanding at a CAGR of 5.30% from 2026 to 2035. The market is rapidly expanding due to the increasing demand for protein-rich foods, commercial poultry and swine farming, and mandatory rules to prevent bacterial infections in livestock amid rising meat consumption.
The US medical devices market size accounted for USD 191.20 billion in 2025 and is predicted to increase from USD 203.06 billion in 2026 to approximately USD 346.19 billion by 2035, expanding at a CAGR of 6.20% from 2026 to 2035. The market growth is attributed to increasing adoption of advanced medical technologies, expanding healthcare infrastructure, and continuous innovation in diagnostic and therapeutic devices.
The US rehabilitation equipment market size accounted for USD 5.19 billion in 2025 and is predicted to increase from USD 5.48 billion in 2026 to approximately USD 9.07 billion by 2035, expanding at a CAGR of 5.74% from 2026 to 2035. The market growth is attributed to increasing disability prevalence, rising rehabilitation service utilization, expanding geriatric populations, and growing adoption of advanced mobility and assistive rehabilitation technologies.
The US AI in medical imaging market size accounted for USD 716.22 billion in 2025 and is predicted to increase from USD 909.63 billion in 2026 to approximately USD 7,640.97 billion by 2035, expanding at a CAGR of 26.71% from 2026 to 2035. The market growth is attributed to rising adoption of AI-powered diagnostic tools, increasing imaging volumes, and expanding FDA-cleared imaging applications across healthcare systems.
The global implantable sensor orthopedic market size accounted for USD 1.06 billion in 2025 and is predicted to increase from USD 3.06 billion in 2026 to approximately USD 13.17 billion by 2035, expanding at a CAGR of 17.04% from 2026 to 2035. The increasing incidence of accidents and chronic diseases, along with further advancements in healthcare devices, support market growth.
The global ceftriaxone sodium market size accounted for USD 2.85 billion in 2025 and is predicted to increase from USD 2.99 billion in 2026 to approximately USD 4.52 billion by 2035, expanding at a CAGR of 4.80% from 2026 to 2035. The market is driven by the increasing global prevalence of severe bacterial infections.
The US nitrile gloves market size accounted for USD 6.88 billion in 2025 and is predicted to increase from USD 7.38 billion in 2026 to approximately USD 14.22 billion by 2035, expanding at a CAGR of 7.53% from 2026 to 2035. The market growth is attributed to increasing healthcare safety requirements, expanding industrial protection standards, and rising demand for contamination control across pharmaceutical, food processing, and advanced manufacturing industries.
The global US gynecological devices market size accounted for USD 4.17 billion in 2025 and is predicted to increase from USD 4.51 billion in 2026 to approximately USD 9.10 billion by 2035, expanding at a CAGR of 8.12% from 2026 to 2035. The increasing adoption of minimally invasive procedures by healthcare professionals to treat women and technological advancements in hydrothermal ablation devices drive the market growth.
The US cell and gene therapy market size accounted for USD 4.09 billion in 2025 and is predicted to increase from USD 4.74 billion in 2026 to approximately USD 20.00 billion by 2035, expanding at a CAGR of 17.21% from 2026 to 2035. The market is experiencing steady growth due to the rising investments in oncology and rare genetic diseases, strategic alliances between industry players and academic institutions, and personalized solutions for common and rare diseases.
The global neuropharmacology market size accounted for USD 156.80 billion in 2025 and is predicted to increase from USD 168.29 billion in 2026 to approximately USD 311.78 billion by 2035, expanding at a CAGR of 7.20% from 2026 to 2035. The increasing prevalence of neurological diseases, advances in research, and the growing number of clinical trials are key factors driving market growth.
The US pharmaceutical excipients market size accounted for USD 3.08 billion in 2025 and is predicted to increase from USD 3.28 billion in 2026 to approximately USD 5.58 billion by 2035, expanding at a CAGR of 6.12% from 2026 to 2035. The market growth is attributed to rising demand for biologics, specialty drugs, and advanced pharmaceutical formulations requiring high-performance excipients.
The US stroke diagnostic and therapeutic market size accounted for USD 6.40 billion in 2025 and is predicted to increase from USD 6.97 billion in 2026 to approximately USD 15.04 billion by 2035, expanding at a CAGR of 8.92% from 2026 to 2035. The market is driven by the increasing adoption of advanced imaging technologies, an escalating incidence of stroke due to aging, and increasing industrial development.
The US skin repair market size accounted for USD 24.47 billion in 2025 and is predicted to increase from USD 25.98 billion in 2026 to approximately USD 47.43 billion by 2035, expanding at a CAGR of 6.84% from 2026 to 2035. The growing focus on reducing skin problems of the people and the surging deployment of advanced technologies in the cosmetics industry drive the market expansion.
The US dermatology market size accounted for USD 477.75 million in 2025 and is predicted to increase from USD 512.05 million in 2026 to approximately USD 973.78 million by 2035, expanding at a CAGR of 7.38% from 2026 to 2035. The market is driven by the increasing prevalence of chronic skin diseases, growing awareness of skin health, and rising demand for minimally invasive cosmetic procedures.
The US cosmeceuticals market size accounted for USD 16.20 billion in 2025 and is predicted to increase from USD 17.58 billion in 2026 to approximately USD 38.27 billion by 2035, expanding at a CAGR of 8.98% from 2026 to 2035. The market growth is attributed to the rising demand for science-backed skincare, biotechnology-derived ingredients, and personalized beauty solutions.
The US pharmacy automation market size was calculated at USD 1.99 billion in 2025 and is predicted to increase from USD 2.19 billion in 2026 to approximately USD 5.22 billion by 2035, expanding at a CAGR of 10.12% from 2026 to 2035. The market growth is attributed to the rising adoption of intelligent medication management systems, expanding digital healthcare infrastructure, and increasing demand for accurate, high-volume prescription dispensing.
The US electron microscopy market size was calculated at USD 1.40 billion in 2025 and is predicted to increase from USD 1.50 billion in 2026 to approximately USD 2.99 billion by 2035, expanding at a CAGR of 7.88% from 2026 to 2035. The market growth is attributed to rising semiconductor investments, expanding nanotechnology research, and increasing demand for atomic-scale characterization capabilities.
The US brachytherapy market size accounted for USD 345.22 million in 2025 and is predicted to increase from USD 370.79 billion in 2026 to approximately USD 699.86 million by 2035, expanding at a CAGR of 7.32% from 2026 to 2035. The market growth is attributed to rising cancer incidence, increasing adoption of precision radiation therapies, and continuous advancements in brachytherapy technologies.